Latest OncoGenex Pharmaceuticals Inc. Stories

2011-08-10 07:00:00

BOTHELL, WA and VANCOUVER, BC, Aug. 10, 2011 /PRNewswire/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that Michelle Burris, OncoGenex' Executive Vice President of Operations and Chief Financial Officer, will be presenting at the 2011 Wedbush Securities Life Sciences Management Access Conference. The OncoGenex corporate presentation will take place on Wednesday, August 17(th) at 3:35pm ET at Le Parker Meridien Hotel in New York City. The...

2011-08-04 16:05:00

BOTHELL, Wash. and VANCOUVER, Aug. 4, 2011 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today provided an update on current events and activities and announced its second quarter financial results. Second Quarter 2011 Highlights Expected timing of results from the survival primary endpoint for the custirsen SYNERGY Phase 3 clinical trial remains unchanged at Q4 2013. During discussions regarding the SATURN Special Protocol Assessment, or SPA, amendment, FDA stated that...

2011-07-28 07:00:00

BOTHELL, WA and VANCOUVER, July 28, 2011 /PRNewswire/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced that the Company's second quarter 2011 financial results will be released on Thursday, August 4, 2011 after the NASDAQ Global Market closes at 4:00 p.m. ET, and that the Company will host a conference call and live webcast at 4:30 p.m. ET that afternoon. Management will discuss the company's financial results and provide an update on the...

Word of the Day
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'